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During recent years the incidence and mortality of Clostridium difficile infection 
(CDI) is increasing, affecting specially to the elderly population[1]. The CDI antibiotic 
treatment can be dissatisfying since protective members of intestinal microbiota are also 
removed and does not prevent recurrent episodes that could end in an antibiotic refractory 
disease[2]. Probiotics have been proposed as a way to restore the microbiota caused by 
antibiotic treatment[3], but it is difficult to choose the correct strain, or bacterial consortium, 
able to be efficient in intervention cases[4]. Thus, it is imperative the rational selection of 
good probiotic candidates to be used in patients; in this regard, there are few models to in 
vitro assess the capability of probiotic candidates to counteract the infection and toxicity of 
C. difficile. 
The purpose of this study was to develop an in vitro real-time assay allowing the 
continuous monitoring of C. difficile toxicity upon human intestinal cells with the final aim to 
select probiotics able to counteract the effect of the pathogen on the host cells. To this end we 
have used the Real Time Cell Analyzer (RTCA xCELLigence, ACEA Bioscienes Inc., San 
Diego, CA, USA) equipment that continuously measures changes in the phenotype and 
behaviour of (adherent) cells using gold microelectrodes that record electrical impedance 
(Figure 1). After the addition of bioactives, cellular events such as growth, morphological 
variations, lysis or apoptosis, will be denoted by modification in the impedance signal.  
 
Figure 1 Real Time Cell Analyzer (RTCA), also known as Real Time Cell Electronic sensing (RT-CES), 
equipment located at IPLA-CSIC.  
 
 
 To develop this model the colonocyte-line intestinal cell line HT29 (ECACC 
91072201, European Collection of Cell Cultures, Salisbury, UK) and the strain Clostridium 
difficille LMG21717 (Belgian Coordinated Collections of Microorganism, Ghent University 
Ghent, Belgium, ∼ ATCC 9689), which produce both A and B toxins, were used. HT29 was 
routinely grown at 37°C, 5% CO2 in supplemented McCoy´s medium (MM) as previously 
described[5]. After trypsin treatment, HT29 cells were seed at 2x106 cells/ ml (100 µl per 
well) in 16-wells E-plates (ACEA Bioscienes Inc.) which were introduced in the holder unit 
of the RTCA-DP and incubated until reach the monolayer state. In this moment different 
percentages of a supernatant collected from C. difficile grown in GAM (Gifu anaerobic 
medium, Gentaur GmbH, Aachen, Germany) at 37°C in anaerobic chamber, were added. 
Supernatants were diluted at concentration ranging from 0.16% to 10% in final 200 µl MM 
medium; a control well (MM without C. difficile supernatant) was also included. Afterwards, 
the behaviour of HT29 monolayer was monitored in real-time to complete a total of 48 h 
follow up. The concentration of toxins A and B produced by C. difficile LMG21717 was 
determined by ELISA tests (tgcBIOMICS GmbH, Bingen, Germany).  
 A representative graphic obtained under these experimental conditions is showed in 
Figure 2A. The impedance signal, determined as the arbitrary unit “cell index” (CI), 
increased from the initial point (0 h, corresponding to cells seed) until reaching stable values 
around 14 h, which indicates that the proliferative state ended and a confluent (monolayer) 
state was reached. The ensure a proper cell differentiation and establishment of strong tight 
junctions in the monolayer, which would mimic the physiological state of the intestinal 
epithelium barrier, this confluent state was maintained for 8 additional hours before adding 
the bioactive to be tested. Thus 22 h after HT29 seeding, C. difficile supernatants were added 
at different concentrations. Two events were detected in the RTCA; in short term, 
immediately after supernatant addition, the CI signal abruptly increased in all wells due to the 
change of medium. Latter the impedance was recovered in the control sample (H) but in all 
samples containing C. difficile supernatants (from A to G) the CI decreased continuously to 
almost reach the value of the initial point (0 h). This behavior indicates that the monolayer 
integrity was compromised due to the detachment of HT29 cells, which was reflected in the 
loss of impedance signal. This event could be directly correlated with the presence of toxins 
in the supernatant of C. difficile LGM21771. Indeed, preliminary results showed that the 
concentration of toxin A and B was 36.97 ± 0.46 and 10.01 ± 1.12 ng/ml, respectively.   
Figure 2 Experimental design to test the toxicity of Clostridium difficille LMG21717 supernatant added in 
McCoy´s medium at different percentages (in duplicated wells) upon the human colonocyte-like cell 
line HT29. The RTCA monitored the cell index (CI) from the initial cells seed to the monolayer 
formation, and after the addition of the supernatants (about 22 h) to the end of the experiment (about 48 
h) (A). For data analysis, CI index values of each well were normalized by the control sample 




After double normalization of the data (respect to the control sample and respect the 
point of supernatant addition) it was detected a doses dependent effect since the reduction in 
the CI, and therefore the toxic effect, was higher in the sample containing the highest 
supernatant concentration and this reduction proportionally diminished when the toxin 
percentages decreased (Figure 2B).  
These results show that we have successfully developed a system to monitor in real 
time the toxic effect of C. difficile upon intestinal cell lines. Currently, we are using the 
method to check the capability of Bifidobacterium strains to counteract this cytotoxic effect 
and the preliminary observations suggest very promising results. The final goal will be the 
selection of a strain (or strains combinations) that could be tested in other complex in vitro 
models, such as fecal slurries harboring the intestinal microbiota of the target human 
population, before to accomplish expensive, time-consuming and Ethical-concerning in vivo 
experiments and intervention studies.   
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